Skip to main content

Table 3 Fertility and clinical status in last control of the patients included in the clinical trial

From: Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial

Variable

Gr. 1. A + LNGIUD + CS [n = 8]

Gr. 2. A + LNGIUD + TUGPA [n = 7]

Gr. 3. LNGIUD + CS [n = 9]

Gr. 4. LNGIUD + TUGPA [n = 7]

Total CT [N = 31]

Years until last control

4.4 ± 1.8

5 ± 1.5

3.4 ± 1.3

4.2 ± 1.3

4.2 ± 1.7

Infertility

1 (12.5)

2 (28.6)

1 (11.1)

0–

4 (12.9)

Pregnancies/deliveries

0–

1 (14.3)x

1 (11.1)

1 (14.3)

3 (9.7)

Clinical status in last control

1. Reoperated

New CS

0

4 (57.1)*

0

3 (42.8)

7 (22.6)

Hyst + Adnexectomy

0–

0–

1 (11.1)

0–

1 (3.2)

2. Persist, well, taking OCP

1 (12.5)

2 (28.6)

0–

2 (28.6)

4 (12.9)

3. Well without medication

7 (87.5)*

1 (14.3)

8 (88.9)**

2 (28.6)

19 (61.3)***

  1. Data are n(%) and mean ± SD. x,1 case reoperation and then pregnancy. Statistical study.– H of Kruskal–Wallis: * between gr1 and gr2 p.004, ** between gr3 and gr4 p.027.—*** Chi-square Pearson among the 4 groups, p.019. A, anastrozole; CT, clinical trial; CS, conservative surgery; Hyst, hysterectomy